MCG Health, part of the Hearst Health network
“The efficient evaluation of chest pain patients can help decongest crowded emergency rooms, and case managers are essential to this process.” – William “Bill” Rifkin, MD, FACP, MCG Associate Vice President and Managing Editor
SEATTLE (PRWEB)
April 06, 2023
MCG Health, part of the Hearst Health network and an industry leader in evidence-based guidance and technology, announces its Associate Vice President and Managing Editor, William “Bill” Rifkin, MD, FACP, will present at the American Case Management Association (ACMA) National Conference happening April 21-24, 2023, in Washington, D.C. The annual ACMA event brings together case management and transitions of care professionals to network, engage with innovators in the field, and discover best practices that improve patient outcomes.
Dr. Rifkin will present the session, “Appropriate Evaluation and Management of Non-Low Risk Chest Pain Patients,” on Friday, April 21, 2023, from 3:30 p.m. to 4:30 p.m. ET. This session will focus on the importance of accurate risk stratification of patients presenting to the emergency department with possible acute coronary conditions. Dr. Rifkin will highlight how appropriate evaluation and interpretation of diagnostic tests can influence clinical decision-making and minimize patient risk for major adverse cardiac events.
“I am excited to return to the national ACMA conference”, said Dr. Rifkin. “The efficient evaluation of chest pain patients can help decongest crowded emergency rooms, and case managers are essential to this process. Based on recent research, there have been significant changes in how chest pain patients are risk-stratified, and case managers are well positioned to help disseminate these changes in their home institutions.”
Dr. Rifkin oversees research, guideline writing, and the development of other content focused on acute inpatient care at MCG. Before joining MCG, he was an Associate Professor of Clinical Medicine and the Director of the Internal Medicine Residency Program at the Jacobi Medical Center/Albert Einstein College of Medicine in the Bronx, New York. Prior to that, he was an academic hospitalist and Associate Residency Program Director at two other New York hospitals and at the Yale Primary Care Internal Medicine Residency Program in New Haven, Connecticut. He has published research in the areas of hospital medicine and quality of clinical care. Dr. Rifkin graduated from the State University of New York Stony Brook School of Medicine, completed his internal medicine training at Lenox Hill Hospital in New York, and is board certified in internal medicine.
To learn more about Dr. Rifkin’s presentation at the ACMA conference, registration details, and additional information can be found at: https://na.eventscloud.com/website/39204/.
About MCG Health
MCG, part of the Hearst Health network, provides unbiased clinical guidance that gives healthcare organizations confidence in delivering patient-centered care. MCG’s artificial intelligence and technology, infused with clinical expertise, enable its clients to prioritize and simplify their work. MCG’s world-class customer service ensures that clients maximize the benefits of licensing MCG solutions – demonstrating improved clinical and financial outcomes. For more information visit http://www.mcg.com or follow our Twitter handle at @MCG_Health.
About Hearst Health
The mission of Hearst Health is to help guide the most important care moments by delivering vital information into the hands of everyone who touches a person’s health journey. Care guidance from Hearst Health reaches the majority of people in the U.S. The Hearst Health network includes FDB (First Databank), Zynx Health, MCG, Homecare Homebase and MHK (formerly MedHOK). Hearst also holds a minority interest in the precision medicine and oncology analytics company M2Gen. Follow Hearst Health on Twitter @HearstHealth and LinkedIn @Hearst-Health.
Share article on social media or email: